Drug
Nascobal Nasal Spray
Nascobal Nasal Spray: highest development phase Phase 1, developed by Swedish Orphan Biovitrum. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Swedish Orphan Biovitrum
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nascobal nasal spray (cyanocobalamin, USP) NCT01306123 | Phase 1 | Focus: Bioavailability |
Latest
No recent events.
Follow Nascobal Nasal Spray on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.